SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

11 Oct 2016 07:00

RNS Number : 1617M
Victrex PLC
11 October 2016
 
 

 

 

 

11 October 2016

Victrex plc: Full year and pre-close trading update

'Improved second half; good finish to 2016'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its full year and pre-close trading update for the financial year ended 30 September 2016, ahead of its preliminary results on 6 December 2016.

In line with expectations, Victrex delivered an improved performance in the second half and a good finish to 2016.

The core business was in growth, with Aerospace and Automotive performing well, and a more stable performance in Oil & Gas during the second half. Sales volumes for the large Consumer Electronics business were delivered on plan during Q4, with overall second half volumes more than double those in the first half. Q4, overall, saw a good performance with Group revenue up 8% to £73.7m (Q4 2015: £68.0m) and Q4 Group sales volume up 9% to 1,216 tonnes (Q4 2015: 1,119 tonnes).

Despite a positive finish to 2016, full year Group revenue declined by 4% to £252.3m (FY2015: £263.5m), reflecting the year on year fall in Consumer Electronics volumes, which were more than 30% down. Full year Group sales volume was down 6% at 3,952 tonnes (FY 2015: 4,217 tonnes).

Medical revenue (Invibio) for the full year of £50.8m (FY 2015: £50.5m) reflects a stable Spine market in the US. Growth outside of the US, in emerging markets, remains positive.

Our mega-programmes continue to make progress, with the Magma Oil & Gas project delivering first meaningful revenues of over £1m in FY16. Incremental investment opportunities aligned to our mega-programmes are also being progressed, which would further support delivery of the Group's downstream strategy and growth pipeline.

 

Outlook

 

As we start our new financial year, our core business remains robust. However, we remain mindful, as previously communicated, that our early planning assumption suggests Consumer Electronics volumes will be significantly lower in 2017, compared to 2016. This would also impact our operating leverage.

 

Whilst we will continue to invest in our 'front end' commercial, marketing and technical functions, to help drive adoption of our mega-programmes, we will also further enhance our ongoing focus on cost efficiency opportunities over the coming year.

 

With a differentiated strategy, a strong pipeline and a highly cash generative business model, Victrex remains in a good position to drive shareholder value for the medium to longer term.

 

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Teneo Blue Rubicon:

Charles Armitstead +44 (0) 207 260 2700

 

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the Automotive, Aerospace, Energy, Electronics and Medical markets. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we deliver leading edge solutions to shape future performance for our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGGBUUUPQGQU
Date   Source Headline
8th Feb 20117:00 amRNSAGM and Interim Management Statement
31st Jan 20114:36 pmRNSTotal Voting Rights
19th Jan 20112:33 pmRNSDirector/PDMR Shareholding
13th Jan 201111:59 amRNSHolding(s) in Company
10th Jan 20117:00 amRNSBoard Change
4th Jan 20113:30 pmRNSAnnual Information Update
4th Jan 20113:21 pmRNSTotal Voting Rights
22nd Dec 201012:43 pmRNSAnnual Financial Report
14th Dec 20103:09 pmRNSDirector/PDMR Shareholding
10th Dec 201012:04 pmRNSDirector/PDMR Shareholding
9th Dec 20109:27 amRNSHolding(s) in Company
8th Dec 20104:16 pmRNSDirector/PDMR Shareholding
8th Dec 201010:00 amRNSHolding(s) in Company
7th Dec 20107:00 amRNSFinal Results
1st Dec 201010:58 amRNSBlocklisting Interim Review
30th Nov 20102:54 pmRNSTotal Voting Rights
17th Nov 20104:07 pmRNSDirector/PDMR Shareholding
16th Nov 20103:38 pmRNSDirector Declaration
1st Nov 20102:11 pmRNSTotal Voting Rights
20th Oct 20102:11 pmRNSDirector/PDMR Shareholding
20th Oct 20102:11 pmRNSDirector/PDMR Shareholding
7th Oct 20107:00 amRNSAnnual Trading Update
1st Oct 20102:01 pmRNSTotal Voting Rights
17th Sep 20101:24 pmRNSDirector/PDMR Shareholding
15th Sep 201012:13 pmRNSHolding(s) in Company
31st Aug 201012:16 pmRNSTotal Voting Rights
17th Aug 20101:05 pmRNSDirector/PDMR Shareholding
5th Aug 20107:00 amRNSInterim Management Statement
5th Aug 20107:00 amRNSBoard Change
3rd Aug 201010:47 amRNSDirector Declaration
28th Jul 201012:53 pmRNSHolding(s) in Company
19th Jul 20102:48 pmRNSDirector/PDMR Shareholding
2nd Jul 20101:06 pmRNSDirector Declaration
30th Jun 20102:46 pmRNSTotal Voting Rights
22nd Jun 201011:06 amRNSDirector/PDMR Shareholding
18th Jun 201012:07 pmRNSDirector/PDMR Shareholding
7th Jun 20101:48 pmRNSDirector/PDMR Shareholding
2nd Jun 20102:37 pmRNSDirector/PDMR Shareholding
2nd Jun 201010:15 amRNSBlocklisting Interim Review
1st Jun 20103:49 pmRNSTotal Voting Rights
1st Jun 20103:34 pmRNSDirector/PDMR Shareholding
25th May 20107:00 amRNSHalf Yearly Report
18th May 20104:28 pmRNSDirector/PDMR Shareholding
30th Apr 201011:58 amRNSTotal Voting Rights
23rd Apr 201010:53 amRNSDirector Declaration
19th Apr 20102:52 pmRNSDirector/PDMR Shareholding
19th Apr 201011:41 amRNSHolding(s) in Company
12th Apr 20103:52 pmRNSHolding(s) in Company
9th Apr 20101:43 pmRNSHolding(s) in Company
8th Apr 20107:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.